Artrya raises $15 million
ASX-listed Artrya, which is commercialising coronary disease diagnosis support products, has announced a successful $15 million raise through a share placement. In a statement on Friday, the company said it had received binding commitments under a two-tranche placement at $0.73 per share. The proceeds will be used to progress regulatory applications for its Salix Coronary…











